Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company PX Biosolutions Pty. Ltd.
DescriptionVaccine containing 3 tumor associated antigens conjugated to DCtag nanoparticles
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today